Maurice H. Tenney
President, Brooks Life Sciences
Brooks Life Sciences President Maurice “Dusty” H. Tenney III is responsible for the company’s growing life sciences business in diverse global markets, where Brooks provides comprehensive biological sample management and cold chain solutions, including:
- automated storage, services and informatics,
- and instruments.
Prior to joining Brooks in 2014, Tenney spent 13 years with PerkinElmer, Inc. in various leadership roles, including senior vice president of its environmental health business. His career includes progressive leadership assignments with GE, Lockheed Martin, AlliedSignal and Honeywell.
Vice President, Automated Solutions Group
Robin joined Brooks in 2014 as part of the FluidX acquisition and now leads the Automated Solutions Group which comprises of Automated -20°C & -80°C Stores, Sample Storage Consumables, Instrumentation to support sample handling and tracking along with the Global Service team for all Brooks Life Sciences products.
The portfolio of active brands include FluidX, Biocision, 4titude, REMP along with supporting legacy brands including Nexus, RTS and Matrical.
Prior to joining Brooks, Robin held a number of progressive leadership positions including Director and co-founder of FLUIDX, Director of European Sales for Matrix Technologies Corp (Thermo-Fisher), General Manager and Product Manager for Cell Culture Instrumentation and a number of technical and scientific positions with MRC (Cambridge) and AstraZeneca, where he focused on cell culture, monoclonal antibody and assay development.
Vice President, Services and Informatics
As Vice President of Services and Informatics at Brooks Life Sciences, Martin Long is responsible for defining and achieving strategic goals and performance targets of the sample storage and management business segment.
Long has been solving science-based problems across the pharmaceutical industry value chain and for adjacent academic research and industries for over 30 years. He has led global businesses that focus on life and analytical science instrumentation, sample preparation, consumables, automation, informatics and lab services.
Prior to Brooks Life Sciences, he was senior director of global marketing and business management for Thermo Fisher Scientific. Long also worked in various executive-level marketing strategy, product and service positions with Perkin Elmer.
He has managed staff and partnered with clients in the United States, Europe, China and Singapore. Long’s career includes responsibilities for developing and maintaining international quality systems and deploying continuous improvement tools to improve business performance and client satisfaction.
Dr. Andrew Brooks
Chief Scientific Officer
Dr. Andy Brooks serves as the Chief Scientific Officer for Brooks Life Sciences.
Dr. Brooks is also the Chief Operating Officer and Director of Technology Development of Rutgers University Cell and DNA Repository (RUCDR)
As the Chief Operating Officer of RUCDR Infinite Biologics, Dr. Brooks oversees the operations of all laboratories within RUCDR, ensuring consistent and superior quality standards for all services.
David Gray, Ph.D.
Senior Vice President, Chief Strategy and New Business Officer
Senior Vice President, Chief Strategy and New Business Officer David Gray, Ph.D., joined Brooks Life Sciences in 2014. He leads next generation product and business initiatives in the life sciences business segment, and currently serves as acting general manager of the cryogenic automation solutions business.
Prior to Brooks, Gray was chief strategy and new business officer at GT Advanced Technologies, Inc., where he held various executive management roles and was responsible for global strategy development and execution, as well as internal product development. Gray spent several years as a mergers and acquisitions strategic advisor to various companies in the technology and life science industries.
He has a bachelor’s degree in chemical engineering from Carnegie Mellon University, a master’s and a doctorate degree in chemical engineering (semiconductor processing) from Massachusetts Institute of Technology, and an MBA from Stanford University.
Head of Strategic Operations and Business Development
As head of strategic operations and business development, Russ Hager oversees operations globally along with supporting mergers and acquisitions activity through due diligence and integration leadership. With a strong background in the FDA-regulated medical device and pharmaceutical industries, he has developed business continuity plans for manufacturing and supply chain operations for major corporations.
Recognized as a subject matter specialist on warehousing and transportation, Hager has extensive experience with domestic and international supply chain management. He is also considered a subject matter expert in cold chain logistics support within GMP (Good Manufacturing Practice) environments. His certifications in Six Sigma, Lean, and Quality provide a robust background in continuous improvement.
Bringing more than 30 years of experience to Brooks, Hager was most recently head of global operations at BioStorage Technologies. He also worked for Abbott Laboratories in roles of progressive responsibility, including senior leadership within global logistics, inventory, distribution, operations and engineering. Hager earned a Bachelor of Science in civil engineering from Purdue University.
Senior Director, Software Engineering
Mark Fish has spent his career designing and implementing customized software solutions for the life science industry. As general manager of informatics for Brooks Life Sciences, he is responsible for global software development for a broad base of customers and applications where Brooks products and services are used.
Prior to joining Brooks, Fish served in leadership roles at RTS Life Science, where he was a business unit director for software and drug delivery and before that, a business unit manager. Fish also spent 11 years at Thermo Fisher Scientific, where he was responsible for helping lead the company’s success by developing innovative products to serve new user requirements and trends in the market.
He graduated from the University of Salford with degrees in chemistry and French. After attaining his bachelor’s degree, Fish studied research and asymmetric catalysis at the University of Manchester. His papers have been widely published in trade publications such as Pharmaceutical Technology Europe, Manufacturing Chemist and Drug Discovery News.